跳至主要内容
临床试验/NCT05227521
NCT05227521已完成1 期

The Feasibility of the Adapted H-GRASP Feedback Program for Perceived and Daily Life UL Activity in Patients With Good Observed But Low Perceived Activity in the Chronic Phase Post Stroke: a Pilot Study.

KU Leuven2 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2022年1月31日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
KU Leuven
入组人数
19
试验地点
2
主要终点
Recruitment rate

研究概览

简要总结

In a recent cross-sectional study, it was shown that people with a good observed upper limb (UL) motor function but low perceived UL activity show a reduced daily-life UL activity. The investigators will now investigate the feasibility of a phone-monitored home exercise and feedback program for the UL following stroke and the preliminary effects on the perceived UL activity and actual daily-life UL activity for participants with good observed UL motor function but low perceived UL activity in the chronic phase post-stroke.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Voluntary written informed consent of the participant has been obtained prior to any screening procedures
  • First-ever unilateral, supratentorial stroke, as defined by the American Heart Association/American Stroke Association
  • Minimum six months after stroke
  • Living in the community
  • ≥18 years old
  • Good observed UL motor function but low perceived UL activity. Good observed UL motor function is defined as a score >50/66 on the Fugl-Meyer Assessment-Upper Extremity (FMA-UE). Low perceived UL activity is defined as a score ≤75/100 on the hand subscale of the Stroke Impact Scale version 3.0 (SIS-Hand).

排除标准

  • Other neurological condition than stroke
  • Musculoskeletal disorder that affects UL use
  • No informed consent
  • Participation in an interventional Study with an investigational medicinal product (IMP) or device

结局指标

主要结局

Recruitment rate

时间窗: 45 days (post-intervention)

% of individuals who were eligible and agreed to participate

Retention rate

时间窗: 45 days (post-intervention)

% of participants who completed the intervention

Safety

时间窗: 45 days (post-intervention)

# of participants with increased pain while performing exercises as measured by visual analogue scale

Adherence to the intervention protocol

时间窗: 45 days (post-intervention)

% of participants who achieved 12 hours of average weekly exercise

Activity ratio

时间窗: 45 days (post-intervention)

Contribution to the activity of one upper limb (UL) versus the other: hours of activity of the affected divided by the unaffected UL

Hand subscale of the Stroke Impact Scale version 3.0 (SIS-Hand)

时间窗: 45 days (post-intervention)

Perceived activity of the affected UL. Minimum 0 - maximum 100; higher scores mean better outcome.

次要结局

  • Action Research Arm Test (ARAT)(Day 17 (baseline), 45 days (post-intervention))
  • Fugl-Meyer motor assessment - upper extremity (FMA-UE)(Day 1 (enrolment), day 17 (baseline), 45 days (post-intervention))
  • Motor Activity Log - 14 Item Version Amount Of Use (MAL-14 AOU)(Day 17 (baseline), 45 days (post-intervention))
  • Motor Activity Log - 14 Item Version Quality Of Movement (MAL-14 QOM)(Day 17 (baseline), 45 days (post-intervention))
  • Erasmus modified Nottingham Sensory Assessment (Em-NSA)(Day 17 (baseline), 45 days (post-intervention))
  • simplified modified Rankin Scale questionnaire (smRSq)(Day 17 (baseline), 45 days (post-intervention))
  • Hospital Anxiety and Depression Scale (HADS)(Day 17 (baseline), 45 days (post-intervention))
  • Confidence in Arm and Hand Movement Scale (CAHM)(Day 17 (baseline), 45 days (post-intervention))
  • Magnitude ratio(Day 1 (enrolment), day 17 (baseline), 45 days (post-intervention))
  • Density plot(Day 1 (enrolment), day 17 (baseline), 45 days (post-intervention))
  • Visual Analogue Scale (VAS)(Day 17 (baseline), 45 days (post-intervention))
  • EuroQol Five Dimensions Five Levels Questionnaire (EQ-5D-5L)(Day 17 (baseline), 45 days (post-intervention))
  • Hours of UL activity(Day 1 (enrolment), day 17 (baseline), 45 days (post-intervention))
  • Bilateral magnitude(Day 1 (enrolment), day 17 (baseline), 45 days (post-intervention))

研究者

发起方
KU Leuven
申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof Geert Verheyden

Professor

KU Leuven

研究点 (2)

Loading locations...

相似试验